Immunos Therapeutics raised €14M in a Series A round in Oct 2019. The company is based in Schlieren, Switzerland. Investors in the round: BioMedPartners, Pfizer Venture Investments. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
